Please login to the form below

Not currently logged in
Email:
Password:

New accounts: November

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive

The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period August to October 2005 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email nhobson@pmlive.com

Allergan

Botox

Neurology

Jango Communications

Amgen European HQ

Aranesp KOL strategy

Oncology

central

Amgen European HQ

Mimpara meetings

Nephrology

central

Amgen European HQ

Neulasta KOL strategy

Oncology

central

GlaxoSmithKline

Cervarix

Cervical cancer (consumer healthcare)

Clew Communications

GlaxoSmithKline

Cervarix

Cervical cancer

Virgo HEALTH PR

Grnenthal

New product launch

N/A

Jango Communications

Haemophilia Society

N/A

Corporate

Red Door Communications

Isolagen UK

Corporate and business programme

N/A

Ruder Finn UK

LiDCO

LiDCO

Intensive care medicine

Reynolds-MacKenzie

MSD

N/A

Internet

LeapFrog Medical

Novartis

Exjade

Sickle cell disease

Avenue

Novartis

Glivec

Oncology - GIST

Avenue

Novartis

N/A

Ophthalmics

LeapFrog Medical

Oxford Immunotec

N/A

N/A

Virgo HEALTH PR

Pfizer

Lyrica

Epilepsy

TVF Communications

Pharmion

N/A

N/A

Virgo HEALTH PR

Procter & Gamble

Asacol

Inflammatory bowel disease

Resolute Communications

Roche

MabThera

Rheumatoid arthritis

Red Door Communications

Roche (global)

Valcyte

Transplantation

central

Viatris Consumer Brands

Osteo-life

Calcium supplement

hsdcommunications

2nd September 2008

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics